Month: April 2024

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce the launch of its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System in the US as a patient-centric option for treating chronic wounds. The system is lightweight and compact allowing it to be easily carried or worn,1 it features a discreet canister, and operates quietly so as not to draw attention or disturb the patients’ daily activities.1It is estimated that the annual financial burden of chronic wounds in the US is $33 billion,2 and affecting some 8.2 million people.*3 The RENASYS EDGE System is designed for patients suffering from these wounds and living at home. Chronic wounds, including ulcers, have a huge impact on a patient’s life beyond just the pain and discomfort, with 68% often becoming self-conscious of their wound and...

NAARDEN, the Netherlands and MIAMI, April 01, 2024 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced the appointment of Juliette Audet as Chief Business Officer (“CBO”), and her simultaneous resignation from the Company’s Board of Directors, both effective April 1, 2024. “We are privileged to welcome Juliette to our management team as CBO,” said Michael Davidson, M.D., Chief Executive Officer of NewAmsterdam. “Juliette has been a trusted advisor to NewAmsterdam as an investor and member...

NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) — SLR Investment Corp. (the “Company”) (NASDAQ: SLRC) today announced that it will release its financial results for the quarter ended March 31, 2024 on Wednesday, May 8, 2024 after the close of the financial markets. The Company will host an earnings conference call and audio webcast at 10:00 a.m. (Eastern Time) on Thursday, May 9, 2024. All interested parties may participate in the conference call by dialing (800) 445-7795 approximately 5-10 minutes prior to the call, international callers should dial (785) 424-1789. Participants should reference SLR Investment Corp. and Conference ID: SLRC1Q24. A telephone replay will be available until May 23, 2024 and can be accessed by dialing (800) 925-9394. International callers should dial (402) 220-5386. This conference call will also be broadcast...

ANN ARBOR, Mich., April 01, 2024 (GLOBE NEWSWIRE) — Esperion (Nasdaq: ESPR) today announced that Sheldon Koenig, President and CEO, will ring the Nasdaq Stock Market (Nasdaq) opening bell at 9:30 a.m. ET today, April 1, 2024, to commemorate the U.S. Food and Drug Administration’s (FDA) recent approval of broad new labels for Esperion’s products. “We are honored to ring the Nasdaq opening bell to celebrate a significant milestone for Esperion,” said Mr. Koenig. “This ceremony marks an opportunity to recognize the progress our team has made in achieving these broad new labels, which will significantly reduce previously existing prescribing limitations. I’m pleased to be joined today by other members of our talented team, who have shown unwavering commitment to Esperion throughout this process and helped to get us to where we are...

SAN DIEGO, April 01, 2024 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the company will participate in two upcoming investor conferences scheduled to take place in April 2024. Details of the conferences appear below: Conference: Evercore ISI Diamonds in the Rough Webinar DayDate: Thursday, April 4, 2024 Time: 10:30am EDTLocation: VirtualFormat: Corporate Presentation with Q&A Session Conference: Piper Sandler Spring Biopharma SymposiumDate: Wednesday, April 17, 2024Location: Everett, MAFormat: 1×1 Investor Meetings For more information on how to register, please contact your Evercore ISI or Piper Sandler representative. About aTyr aTyr is...

Geneva, Switzerland, April 01, 2024 (GLOBE NEWSWIRE) — SEALSQ Corp (“SEALSQ” or “Company”) (NASDAQ: LAES), a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum technology hardware and software products, today announced that its PKI-as-a-Service solution “INeS” has been selected by D-Link, a global leader in networking solutions, to provide Node Attestation Certificates for D-Link’s MS30-N, MS30, and MS60-I Matter-compliant IoT Gateways. “SEALSQ’s INeS platform enables D-Link MS30-N, MS30, and MS60 IoT gateways to offer features like faster connection to a Matter ecosystem for the devices they manufacture. Additionally, it provides higher flexibility for D-Link to manage certificates at design and manufacturing stages,” said Frank Buonnano, VP of Global Sales for SEALSQ. He...

VANCOUVER, British Columbia, April 01, 2024 (GLOBE NEWSWIRE) — AlphaGen Intelligence Corp. (CSE: AIC | OTC: APETF | FSE: W4V) (“AlphaGen” or the “Company”), a leader in AI technology for 3D entertainment, ecommerce, and content is excited to announce the beta launch of the world’s largest virtual beauty metropolis. This marks a significant milestone in AlphaGen’s journey, following the multi-million dollar contract with a major retail client beginning in 2023. The virtual beauty metropolis elevates ecommerce experiences by offering an immersive platform for brands that bridges the gap between virtual and physical beauty retail. AlphaGen’s approach to creating virtual worlds underscores the company’s leadership in capitalizing on the Metaverse opportunity, which Citibank projects could be worth up to $13 trillion by...

DUBLIN, Ireland, April 01, 2024 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the 23rd Annual Needham Healthcare Conference on Monday, April 8 at 10:15 a.m. ET. A live webcast of the fireside chat, as well as an archived recording, will be available on Avadel’s Investor Relations website, investors.avadel.com, for 90 days following the conference. About Avadel Pharmaceuticals plc Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment...

MONTREAL and CHARLOTTE, N.C., April 01, 2024 (GLOBE NEWSWIRE) — Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that it will present data on etripamil at two upcoming cardiology conferences this month. The company will deliver oral and poster presentations at the American College of Cardiology annual meeting (ACC24), to be held April 6-8th in Atlanta, Georgia, and a poster presentation at the annual meeting of the European Heart Rhythm Association (EHRA), to be held April 7-9th in Berlin, Germany. The presentations will be available following the embargo at https://MilestonePharma.com.ACC Presentation Details: Oral Presentation Title:   Multi-Center, Open-Label Study of the Efficacy and Safety...

MALVERN, Pa., April 01, 2024 (GLOBE NEWSWIRE) — Vishay Intertechnology, Inc., (NYSE: VSH) announced today that its Annual Meeting of Stockholders will be held at 9:00 a.m., U.S. eastern time, on Tuesday, May 21, 2024. Vishay has adopted a virtual annual meeting in 2024. The annual meeting will be accessible to stockholders via the Internet at www.virtualshareholdermeeting.com/VSH2024.  United States Securities and Exchange Commission rules allow the Company to mail a notice to its stockholders advising that its proxy statement, annual report to stockholders, electronic proxy card and related materials are available for viewing, free of charge, on the Internet. Stockholders may then access these materials and vote over the Internet or request delivery of a full set of materials by mail or email. Vishay has elected to utilize this...